脊髓麻醉剂量对初次全膝关节置换术住院时长的影响
发现脊髓麻醉布比卡因剂量≤1.6 mL者住院时长比>1.6 mL者缩短6小时(P<0.001),剂量与住院时长呈强剂量-反应关系,每增加0.1 mL住院时长增加49分钟。
要点
- 布比卡因剂量≤1.6 mL者住院时长比>1.6 mL者缩短6小时(P<0.001)。
- 多变量回归显示麻醉剂量(β=8.2,P=0.03)和年龄(β=0.31,P=0.004)预测住院时长增加。
- 布比卡因每增加0.1 mL,住院时长增加49分钟,呈强剂量-反应关系。
核心结论
- 在控制提供者、手术和患者因素后,脊髓麻醉布比卡因剂量是初次全膝关节置换术住院时长的强预测因子。
- 优化脊髓麻醉方案 targeting 较低麻醉剂量可能是加速康复管理的重要方向。
研究设计与样本
- 收集人口学、合并症、外科医生、麻醉医生、脊髓麻醉细节及住院时长,进行单变量和多变量分析。
主要发现
- 住院时长最大增幅出现在剂量大于1.6 mL时。
- 接受≤1.6 mL布比卡因者住院时长比>1.6 mL者缩短6小时(P<0.001)。
- 多变量回归中,麻醉剂量(β=8.2,P=0.03)和年龄(β=0.31,P=0.004)预测住院时长增加,男性预测住院时长降低(β=-6.56,P=0.003)。
- 布比卡因每增加0.1 mL,住院时长增加49分钟。
关键数值与推荐
- 布比卡因剂量≤1.6 mL与>1.6 mL的住院时长差异为6小时(P<0.001)。
- 多变量回归中麻醉剂量β=8.2(P=0.03),年龄β=0.31(P=0.004),男性β=-6.56(P=0.003)。
- 布比卡因每增加0.1 mL,住院时长增加49分钟。
临床怎么用
- 在HOPD全膝关节置换术中,可考虑采用较低剂量布比卡因的脊髓麻醉方案以缩短住院时长。
- 麻醉剂量是住院时长的可调控预测因子,优化麻醉协议可能促进加速康复。
局限性
- 单中心回顾性研究,仅纳入使用布比卡因者,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The implementation of neuraxial anesthesia in total knee arthroplasty (TKA) has been shown to shorten hospital lengths of stay (LOSs) compared to general anesthesia. Despite these advances, LOS for TKA in a hospital outpatient department (HOPD) setting remains high. We examined the association between the dose of neuraxial anesthesia and LOS in patients undergoing primary TKA. METHODS: A retrospective review of internal medical records for patients who underwent primary TKA at a single institution from June 1, 2024, to December 31, 2024, was performed. Demographic data, comorbidities, surgeon, anesthesiologist details, neuraxial anesthetic details, and LOS were collected. For uniformity, only patients who received bupivacaine were included. Univariate and multivariable analyses were conducted. A total of 1,486 primary TKA patients were included in the study. RESULTS: The largest increase in LOS occurred at a dosage greater than 1.6 mL. Patients who received 1.6 mL or less of neuraxial bupivacaine had a 6-hour shorter LOS than those who received more than 1.6 mL (P < 0.001). Multivariate regression analyses revealed that the dose of neuraxial anesthetic (β = 8.2, P = 0.03) and age (β = 0.31, P = 0.004) were predictors of increased LOS. Being a man was predictive of lower LOS (β = -6.56, P = 0.003). CONCLUSIONS: In this study of primary HOPD TKA, dose of bupivacaine administered for neuraxial anesthesia was a strong predictor for LOS when controlling for provider, procedural, and patient-level factors. A 0.1 mL increase in bupivacaine dosing was associated with an increase in LOS by 49 minutes, and a strong dose-response relationship was noted between anesthetic dose and LOS. This finding suggests that optimized neuraxial anesthesia protocols targeting lower anesthetic doses may be the next important frontier in expedited recovery management in HOPD TKA.
引用
- Kuznetsov M, Playter KP, Travers HI, et al. The Impact of Spinal Anesthetic Dose on Lengths of Stay in Primary Total Knee Arthroplasty. J Arthroplasty. 2026. PMID: 42303007. doi:10.1016/j.arth.2026.06.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。